α-Synuclein Iron-Responsive-Element RNA and Iron Regulatory Protein Affinity Is Specifically Reduced by Iron in Parkinson’s Disease
Abstract
:1. Introduction
2. Materials and Methods
2.1. Preparation of RNA and Protein
2.2. RNA Secondary Structure Predictions
2.3. Fluorescence Spectroscopy Measurement
2.4. Determination of Binding Site
2.5. Effect of Fe2+ on α-Syn IRE RNA•IRP1 Complex
2.6. Influence of Temperature on α-Syn IRE RNA∙IRP1 Interaction
2.7. Thermostability Analysis of α-Syn IRE RNA Binding to IRP1
2.8. Circular Dichroism (CD) Measurements
2.9. Statistical Analysis
3. Result
3.1. Functional α-Synuclein IRE Is Encoded by 5′-UTR Transcript
3.2. Iron Weakens α-Syn IRE RNA’s Affinity to IRP1
3.3. Therma Stability Characterization of α-Syn IRE RNA•IRP1
3.4. Thermodynamic Characteristics of α-Syn IRE RNA Binding to IRP1
3.5. Conformational Alteration of IRP1 upon Binding to α-Syn IRE RNA
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Tysnes, O.B.; Storstein, A. Epidemiology of Parkinson’s disease. J. Neural Transm. 2017, 124, 901–905. [Google Scholar] [CrossRef] [PubMed]
- Spillantini, M.G.; Schmidt, M.L.; Lee, V.M.Y.; Trojanowski, J.Q.; Jakes, R.; Goedert, M. α-synuclein in Lewy bodies. Nature 1997, 388, 839–840. [Google Scholar] [CrossRef] [PubMed]
- Morris, H.R.; Spillantini, M.G.; Sue, C.M.; Williams-Gray, C.H. The pathogenesis of Parkinson’s disease. Lancet 2024, 403, 293–304. [Google Scholar] [CrossRef] [PubMed]
- Spillantini, M.G.; Goedert, M. The α-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann. N. Y. Acad. Sci. 2000, 920, 16–27. [Google Scholar] [CrossRef] [PubMed]
- Polymeropoulos, M.H.; Lavedan, C.; Leroy, E.; Ide, S.E.; Dehejia, A.; Dutra, A.; Dutra, A.; Pike, B.; Root, H.; Rubenstein, J.; et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 1997, 276, 2045–2047. [Google Scholar] [CrossRef] [PubMed]
- Goedert, M.; Jakes, R.; Spillantini, M.G. The Synucleinopathies: Twenty Years On. J. Parkinsons Dis. 2017, 7, S51–S69. [Google Scholar] [CrossRef] [PubMed]
- Zarranz, J.J.; Alegre, J.; Gómez-Esteban, J.C.; Lezcano, E.; Ros, R.; Ampuero, I.; Vidal, L.; Hoenicka, J.; Rodriguez, O.; Atarés, B.; et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004, 55, 164–173. [Google Scholar] [CrossRef]
- Appel-Cresswell, S.; Vilarino-Guell, C.; Encarnacion, M.; Sherman, H.; Yu, I.; Shah, B.; Weir, D.; Thompson, C.; Szu-Tu, C.; Trinh, J.; et al. α-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’s disease. Mov. Disord. 2013, 28, 811–813. [Google Scholar] [CrossRef]
- Chartier-Harlin, M.C.; Kachergus, J.; Roumier, C.; Mouroux, V.; Douay, X.; Lincoln, S.; Levecque, C.; Larvor, L.; Andrieux, J.; Hulihan, M.; et al. Causal relation between α-synuclein gene duplication and familial Parkinson’s disease. Lancet 2004, 364, 1169–1171. [Google Scholar] [CrossRef]
- Zhang, P.; Park, H.-J.; Zhang, J.; Junn, E.; Andrews, R.J.; Velagapudi, S.P.; Abegg, D.; Vishnu, K.; Costales, M.G.; Childs-Disney, J.L.; et al. Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA. Proc. Natl. Acad. Sci. USA 2020, 117, 1457–1467. [Google Scholar] [CrossRef] [PubMed]
- Velagapudi, S.P.; Gallo, S.M.; Disney, M.D. Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat. Chem. Biol. 2014, 10, 291–297. [Google Scholar] [CrossRef] [PubMed]
- Luk, K.C.; Kehm, V.; Carroll, J.; Zhang, B.; O’Brien, P.; Trojanowski, J.Q.; Lee, V.M.Y. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338, 949–953. [Google Scholar] [CrossRef] [PubMed]
- Goldstein, D.S.; Isonaka, R.; Lamotte, G.; Kaufmann, H. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies. Clin. Auton. Res. 2021, 31, 677–684. [Google Scholar] [CrossRef]
- Nechushtai, L.; Frenkel, D.; Pinkas-Kramarski, R. Autophagy in Parkinson’s Disease. Biomolecules 2023, 13, 1435. [Google Scholar] [CrossRef] [PubMed]
- Malpartida, A.B.; Williamson, M.; Narendra, D.P.; Wade-Martins, R.; Ryan, B.J. Mitochondrial Dysfunction and Mitophagy in Parkinson’s Disease: From Mechanism to Therapy. Trends Biochem. Sci. 2021, 46, 329–343. [Google Scholar] [CrossRef] [PubMed]
- Schmukler, E.; Pinkas-Kramarski, R. Autophagy induction in the treatment of Alzheimer’s disease. Drug Dev. Res. 2020, 81, 184–193. [Google Scholar] [CrossRef] [PubMed]
- Burré, J.; Sharma, M.; Südhof, T.C. Cell Biology and Pathophysiology of α-Synuclein. Cold Spring Harb. Perspect. Med. 2018, 8, a024091. [Google Scholar] [CrossRef]
- Bartels, T.; Choi, J.G.; Selkoe, D.J. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 2011, 477, 107–110. [Google Scholar] [CrossRef] [PubMed]
- Fusco, G.; De Simone, A.; Gopinath, T.; Vostrikov, V.; Vendruscolo, M.; Dobson, C.M.; Veglia, G. Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour. Nat. Commun. 2014, 5, 3827. [Google Scholar] [CrossRef]
- Vamvaca, K.; Volles, M.J.; Lansbury, P.T., Jr. The first N-terminal amino acids of α-synuclein are essential for α-helical structure formation in vitro and membrane binding in yeast. J. Mol. Biol. 2009, 389, 413–424. [Google Scholar] [CrossRef] [PubMed]
- Nielsen, M.S.; Vorum, H.; Lindersson, E.; Jensen, P.H. Ca2+ binding to α-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 2001, 276, 22680–22684. [Google Scholar] [CrossRef]
- Lautenschläger, J.; Stephens, A.D.; Fusco, G.; Stroehl, F.; Curry, N.; Zacharopoulou, M.; Michel, C.H.; Laine, R.; Nespovitaya, N.; Fantham, M.; et al. C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction. Nat. Commun. 2018, 9, 712. [Google Scholar] [CrossRef]
- Carapeto, A.P.; Marcuello, C.; Faísca, P.F.N.; Rodrigues, M.S. Morphological and Biophysical Study of S100A9 Protein Fibrils by Atomic Force Microscopy Imaging and Nanomechanical Analysis. Biomolecules 2024, 14, 1091. [Google Scholar] [CrossRef] [PubMed]
- Fleming, R.E.; Ponka, P. Iron overload in human disease. N. Engl. J. Med. 2012, 366, 348–359. [Google Scholar] [CrossRef]
- Khan, M.A. Targeting iron responsive elements (IREs) of APP mRNA into novel therapeutics to control the translation of amyloid-β precursor protein in Alzheimer’s disease. Pharmaceuticals 2024, 17, 1669. [Google Scholar] [CrossRef]
- Kruszewski, M. Labile iron pool: The main determinant of cellular response to oxidative stress. Mutat. Res. 2003, 531, 81–92. [Google Scholar] [CrossRef] [PubMed]
- Uversky, V.N.; Li, J.; Fink, A.L. Evidence for a partially folded intermediate in α-synuclein fibril formation. J. Biol. Chem. 2001, 276, 10737–10744. [Google Scholar] [CrossRef] [PubMed]
- Dexter, D.T.; Carayon, A.; Javoy-Agid, F.; Agid, Y.; Wells, F.R.; Daniel, S.E.; Lees, A.J.; Jenner, P.; Marsden, C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114, 1953–1975. [Google Scholar] [CrossRef] [PubMed]
- Faucheux, B.A.; Martin, M.; Beaumont, C.; Hunot, S.; Hauw, J.; Agid, Y.; Hirsch, E.C. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson’s disease. J. Neurochem. 2002, 83, 320–330. [Google Scholar] [CrossRef] [PubMed]
- Febbraro, F.; Giorgi, M.; Caldarola, S.; Loreni, F.; Romero-Ramos, M. α-Synuclein expression is modulated at the translational level by iron. NeuroReport 2012, 23, 576–580. [Google Scholar] [CrossRef] [PubMed]
- McDowall, J.S.; Brown, D.R. α-synuclein: Relating metals to structure, function and inhibition. Met. Integr. Biometal Sci. 2016, 8, 385–397. [Google Scholar] [CrossRef]
- Zhou, Z.D.; Tan, E.-K. Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases. Mol. Neurodegener. 2017, 12, 75. [Google Scholar] [CrossRef] [PubMed]
- Friedlich, A.L.; Tanzi, R.E.; Rogers, J.T. The 5′-untranslated region of Parkinson’s disease α-synuclein messengerRNA contains a predicted iron responsive element. Mol. Psychiatry 2007, 12, 222–223. [Google Scholar] [CrossRef] [PubMed]
- Rogers, J.T.; Randall, J.D.; Cahill, C.M.; Eder, P.S.; Huang, X.; Gunshin, H.; Leiter, L.; McPhee, J.; Sarang, S.S.; Utsuki, T.; et al. An iron-responsive element type II in the 5′-untranslated region of the Alzheimer’s amyloid precursor protein transcript. J. Biol. Chem. 2002, 277, 45518–45528. [Google Scholar] [CrossRef] [PubMed]
- Selezneva, A.I.; Cavigiolio, G.; Theil, E.C.; Walden, W.E.; Volz, K. Crystallization and preliminary X-ray diffraction analysis of iron regulatory protein 1 in complex with ferritin IRE RNA. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2006, 62 Pt 3, 249–252. [Google Scholar] [CrossRef] [PubMed]
- Brazzolotto, X.; Timmins, P.; Dupont, Y.; Moulis, J.M. Structural changes associated with switching activities of human iron regulatory protein 1. J. Biol. Chem. 2002, 277, 11995–12000. [Google Scholar] [CrossRef]
- Khan, M.A.; Mohammad, T.; Malik, A.; Hassan, M.I.; Domashevskiy, A.V. Iron response elements (IREs)-mRNA of Alzheimer’s amyloid precursor protein binding to iron regulatory protein (IRP1): A combined molecular docking and spectroscopic approach. Sci. Rep. 2023, 13, 5073. [Google Scholar] [CrossRef] [PubMed]
- Volpon, L.; Osborne, M.J.; Topisirovic, I.; Siddiqui, N.; Borden, K.L. Cap-free structure of eIF4E suggests a basis for conformational regulation by its ligands. EMBO J. 2006, 25, 5138–5149. [Google Scholar] [CrossRef]
- Khan, M.A.; Malik, A.; Domashevskiy, A.V.; San, A.; Khan, J.M. Interaction of ferritin iron responsive element (IRE) mRNA with translation initiation factor eIF4F. Spectrochim. Acta Part A Mol. Biomol. Spectrscopy 2020, 243, 118776. [Google Scholar] [CrossRef] [PubMed]
- Khan, M.A.; Walden, W.E.; Goss, D.J.; Theil, E.C. Direct Fe2+ sensing by iron-responsive messenger RNA:repressor complexes weakens binding. J. Biol. Chem. 2009, 284, 30122–30128. [Google Scholar] [CrossRef]
- Ke, Y.; Wu, J.; Leibold, E.A.; Walden, W.E.; Theil, E.C. Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation? J. Biol. Chem. 1998, 273, 23637–23640. [Google Scholar] [CrossRef] [PubMed]
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef] [PubMed]
- Reuter, J.S.; Mathews, D.H. RNAstructure: Software for RNA secondary structure prediction and analysis. BMC Bioinform. 2010, 11, 129. [Google Scholar] [CrossRef]
- Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31, 3406–3415. [Google Scholar] [CrossRef]
- Zhang, Y.; Wang, J.; Xiao, Y. 3dRNA: 3D Structure Prediction from Linear to Circular RNAs. J. Mol. Biol. 2022, 434, 167452. [Google Scholar] [CrossRef] [PubMed]
- Biesiada, M.; Pachulska-Wieczorek, K.; Adamiak, R.W.; Purzycka, K.J. RNAComposer and RNA 3D structure prediction for nanotechnology. Methods 2016, 103, 120–127. [Google Scholar] [CrossRef] [PubMed]
- Khan, M.A.; Walden, W.E.; Theil, E.C.; Goss, D.J. Thermodynamic and kinetic analyses of iron response element (IRE)-mRNA binding to iron regulatory protein, IRP1. Sci. Rep. 2017, 7, 8532. [Google Scholar] [CrossRef]
- Chen, Y.H.; Yang, J.T.; Martinez, H.M. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 1972, 11, 4120–4131. [Google Scholar] [CrossRef]
- Volz, K. The functional duality of iron regulatory protein 1. Curr. Opin. Struct. Biol. 2008, 18, 106–111. [Google Scholar] [CrossRef] [PubMed]
- Theil, E.C. Coordinating responses to iron and oxygen stress with DNA and mRNA promoters: The ferritin story. Biometals Int. J. Role Met. Ions Biol. Biochem. Med. 2007, 20, 513–521. [Google Scholar] [CrossRef] [PubMed]
- Olivares, D.; Huang, X.; Branden, L.; Greig, N.H.; Rogers, J.T. Physiological and pathological role of α-synuclein in Parkinson’s disease through iron mediated oxidative stress; the role of a putative iron-responsive element. Int. J. Mol. Sci. 2009, 10, 1226–1260. [Google Scholar] [CrossRef] [PubMed]
- Rogers, J.T.; Randall, J.D.; Eder, P.S.; Huang, X.; Bush, A.I.; Tanzi, R.E.; Venti, A.; Payton, S.M.; Giordano, T.; Nagano, S.; et al. Alzheimer’s disease drug discovery targeted to the APP mRNA 5′untranslated region. J. Mol. Neurosci. 2002, 19, 77–82. [Google Scholar] [CrossRef]
- Leipuviene, R.; Theil, E.C. The family of iron responsive RNA structures regulated by changes in cellular iron and oxygen. Cell. Mol. Life Sci. 2007, 64, 2945–2955. [Google Scholar] [CrossRef] [PubMed]
- Muckenthaler, M.U.; Galy, B.; Hentze, M.W. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 2008, 28, 197–213. [Google Scholar] [CrossRef]
- Shen, M.; Goforth, J.B.; Eisenstein, R.S. Iron-dependent post transcriptional control of mitochondrial aconitase expression. Met. Integr. Biometal Sci. 2023, 15, mfac099. [Google Scholar] [CrossRef] [PubMed]
- Cho, H.-H.; Cahill, C.M.; Vanderburg, C.R.; Scherzer, C.R.; Wang, B.; Huang, X.; Rogers, J.T. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J. Biol. Chem. 2010, 285, 31217–31232. [Google Scholar] [CrossRef] [PubMed]
- Mikkilineni, S.; Cantuti-Castelvetri, I.; Cahill, C.M.; Balliedier, A.; Greig, N.H.; Rogers, J.T. The anticholinesterase phenserine and its enantiomer posiphen as 5′untranslated-region-directed translation blockers of the Parkinson’s alpha synuclein expression. Park. Dis. 2012, 2012, 142372. [Google Scholar] [CrossRef] [PubMed]
- Goforth, J.B.; Anderson, S.A.; Nizzi, C.P.; Eisenstein, R.S. Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy. RNA 2010, 16, 154–169. [Google Scholar] [CrossRef] [PubMed]
- Piccinelli, P.; Samuelsson, T. Evolution of the iron-responsive element. RNA 2007, 13, 952–966. [Google Scholar] [CrossRef]
- Gao, K.; Oerlemans, R.; Groves, M.R. Theory and applications of differential scanning fluorimetry in early-stage drug discovery. Biophys. Rev. 2020, 12, 85–104. [Google Scholar] [CrossRef] [PubMed]
- Khrapunov, S. Circular dichroism spectroscopy has intrinsic limitations for protein secondary structure analysis. Anal. Biochem. 2009, 389, 174–176. [Google Scholar] [CrossRef] [PubMed]
- Rodger, A.; Marrington, R.; Roper, D.; Windsor, S. Circular dichroism spectroscopy for the study of protein-ligand interactions. Methods Mol. Biol. 2005, 305, 343–364. [Google Scholar] [PubMed]
- Rabbani, G.; Kaur, J.; Ahmad, E.; Khan, R.H.; Jain, S.K. Structural characteristics of thermostable immunogenic outer membrane protein from Salmonella enterica serovar Typhi. Appl. Microbiol. Biotechnol. 2014, 98, 2533–2543. [Google Scholar] [CrossRef] [PubMed]
- Khan, M.A.; Kumar, Y.; Tayyab, S. Bilirubin binding properties of pigeon serum albumin and its comparison with human serum albumin. Int. J. Biol. Macromol. 2002, 30, 171–178. [Google Scholar] [CrossRef] [PubMed]
- Cahill, C.M.; Lahiri, D.K.; Huang, X.; Rogers, J.T. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim. Biophys. Acta 2009, 1790, 615–628. [Google Scholar] [CrossRef] [PubMed]
- Hintze, K.J.; Theil, E.C. DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression. Proc. Natl. Acad. Sci. USA 2005, 102, 15048–15052. [Google Scholar] [CrossRef]
- Ma, J.; Haldar, S.; Khan, M.A.; Das Sharma, S.; Merrick, W.C.; Theil, E.C.; Goss, D.J. Fe2+ binds iron responsive element-RNA, selectively changing protein-binding affinities and regulating mRNA repression and activation. Proc. Natl. Acad. Sci. USA 2012, 109, 8417–8422. [Google Scholar] [CrossRef]
- Ross, P.D.; Subramanian, S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry 1981, 20, 3096–3102. [Google Scholar] [CrossRef] [PubMed]
- Khan, M.A. Ferritin iron responsive elements (IREs) mRNA interacts with eIF4G and activates in vitro translation. Front. Biosci. (Elite Ed.) 2022, 14, 17. [Google Scholar] [CrossRef]
- Tayyab, S.; Sam, S.E.; Kabir, M.Z.; Ridzwan, N.F.W.; Mohamad, S.B. Molecular interaction study of an anticancer drug, ponatinib with human serum albumin using spectroscopic and molecular docking methods. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2019, 214, 199–206. [Google Scholar] [CrossRef] [PubMed]
- Kuntz, I.D.; Chen, K.; Sharp, K.A.; Kollman, P.A. The maximal affinity of ligands. Proc. Natl. Acad. Sci. USA 1999, 96, 9997–10002. [Google Scholar] [CrossRef]
- Williams, D.J.; Hall, K.B. RNA hairpins with non-nucleotide spacers bind efficiently to the human U1A protein. J. Mol. Biol. 1996, 257, 265–275. [Google Scholar] [CrossRef] [PubMed]
- Bannister, W.H.; Bannister, J.V. Evidence for the validity of three-component fitting of protein circular dichroism spectra. Z. Naturforsch. C Biosci. 1974, 29, 9–11. [Google Scholar] [CrossRef] [PubMed]
- Masuda, T.; Goto, F.; Yoshihara, T.; Mikami, B. The universal mechanism for iron translocation to the ferroxidase site in ferritin, which is mediated by the well conserved transit site. Biochem. Biophys. Res. Commun. 2010, 400, 94–99. [Google Scholar] [CrossRef]
- Khan, M.A.; Domashevskiy, A.V. Iron enhances the binding rates and translational efficiency of iron responsive elements (IREs) mRNA with initiation factor eIF4F. PLoS ONE 2021, 16, e0250374. [Google Scholar] [CrossRef] [PubMed]
- Ward, R.J.; Zucca, F.A.; Duyn, J.H.; Crichton, R.R.; Zecca, L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014, 13, 1045–1060. [Google Scholar] [CrossRef] [PubMed]
Complex | Kd (nM) | |||||
---|---|---|---|---|---|---|
5 °C | 10 °C | 15 °C | 20 °C | 25 °C | 30 °C | |
α-Syn IRE∙IRP1 | 13.5 ± 0.6 | 21.9 ± 0.8 | 27.8 ± 1.2 | 38.9 ± 1.5 | 47.6 ± 1.7 | 63.8 ± 3.2 |
α-Syn IRE∙IRP1-Fe2+ | 29.6 ± 1.5 | 54.4 ± 2.6 | 88.7 ± 3.8 | 123.6 ± 6.3 | 157 ± 7.7 | 198.7 ± 7.4 |
Complex | ΔH (kJ/mol) | ΔS (J/mol/K) | ΔG (kJ/mol) | TΔS/ΔG (%) |
---|---|---|---|---|
α-Syn IRE∙IRP1 | −42.2 ± 2.3 | 7.0 ± 0.4 | −43.7 ± 2.7 | 4.8 |
α-Syn IRE∙IRP1-Fe2+ | −53.0 ± 4.6 | 48.0 ± 2.7 | −36.3 ± 2.1 | 39.4 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Khan, M.A. α-Synuclein Iron-Responsive-Element RNA and Iron Regulatory Protein Affinity Is Specifically Reduced by Iron in Parkinson’s Disease. Biomolecules 2025, 15, 214. https://doi.org/10.3390/biom15020214
Khan MA. α-Synuclein Iron-Responsive-Element RNA and Iron Regulatory Protein Affinity Is Specifically Reduced by Iron in Parkinson’s Disease. Biomolecules. 2025; 15(2):214. https://doi.org/10.3390/biom15020214
Chicago/Turabian StyleKhan, Mateen A. 2025. "α-Synuclein Iron-Responsive-Element RNA and Iron Regulatory Protein Affinity Is Specifically Reduced by Iron in Parkinson’s Disease" Biomolecules 15, no. 2: 214. https://doi.org/10.3390/biom15020214
APA StyleKhan, M. A. (2025). α-Synuclein Iron-Responsive-Element RNA and Iron Regulatory Protein Affinity Is Specifically Reduced by Iron in Parkinson’s Disease. Biomolecules, 15(2), 214. https://doi.org/10.3390/biom15020214